Mutation analysis of the Gadd45 gene at exon 4 in atypical fibroxanthoma

BMC Dermatology

Volumn 9, Issue , 2009, Pages

  Sakamoto, Akio ^a   Akieda, Shizuka ^a   Oda, Yoshinao ^a   Iwamoto, Yukihide ^a   Tsuneyoshi, Masazumi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; PROTEIN BAX; PROTEIN P53; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; NUCLEAR PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOFIBROMA; DNA DAMAGE; EXON; FEMALE; FIBROXANTHOMA; GENE EXPRESSION; GENE SEQUENCE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; ADOLESCENT; GENETICS; METABOLISM; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PATHOLOGY; SKIN; SKIN TUMOR;

ADOLESCENT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE PROTEINS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HISTIOCYTOMA, BENIGN FIBROUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NUCLEAR PROTEINS; SKIN; SKIN NEOPLASMS;

EID: 59049099755     PISSN: None     EISSN: 14715945     Source Type: Journal    
DOI: 10.1186/1471-5945-9-1     Document Type: Article

References (37)

1. Dahl I Atypical fibroxanthoma of the skin. A clinico-pathological study of 57 cases Acta Pathol Microbiol Scand [A] 1976, 84:183-197. 1258644
2. Enzinger FM Weiss SW Soft tissue tumors St. Louis: CV Mosby; 1995.
3. Fretzin DF Helwig EB Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases Cancer 1973, 31:1541-1552. 10.1002/ 1097-0142(197306)31:6<1541::AID-CNCR2820310635>3.0.CO;2-6 4709969
4. Calonje E Wadden C Wilson-Jones E Fletcher CD Spindle-cell non-pleomorphic atypical fibroxanthoma: Analysis of a series and delineation of a distinctive variant Histopathology 1993, 22:247-254. 10.1111/j.1365-2559.1993.tb00114.x 7684354
5. Dei Tos AP Maestro R Doglioni C Gasparotto D Boiocchi M Laurino L Fletcher CD Ultraviolet-induced p53 mutations in atypical fibroxanthoma Am J Pathol 1994, 145:11-17. 1887293 8030743
6. Ko LJ Prives C p53: Puzzle and paradigm Genes Dev 1996, 10:1054-1072. 10.1101/gad.10.9.1054 8654922
7. Kirkin V Joos S Zornig M The role of Bcl-2 family members in tumorigenesis Biochim Biophys Acta 2004, 1644:229-249. 10.1016/ j.bbamcr.2003.08.009 14996506
8. Yin C Knudson CM Korsmeyer SJ Van Dyke T Bax suppresses tumorigenesis and stimulates apoptosis in vivo Nature 1997, 385:637-640. 10.1038/ 385637a0 9024662
9. Xiang H Kinoshita Y Knudson CM Korsmeyer SJ Schwartzkroin PA Morrison RS Bax involvement in p53-mediated neuronal cell death J Neurosci 1998, 18:1363-1373. 9454845
10. Wang XW Zhan Q Coursen JD Khan MA Kontny HU Yu L Hollander MC O'Connor PM Fornace AJ Jr Harris CC GADD45 induction of a G2/M cell cycle checkpoint Proc Natl Acad Sci USA 1999, 96:3706-3711. 22358 10097101 10.1073/pnas.96.7.3706
11. Hollander MC Sheikh MS Bulavin DV Lundgren K Augeri-Henmueller L Shehee R Molinaro TA Kim KE Tolosa E Ashwell JD et al Genomic instability in Gadd45a-deficient mice Nat Genet 1999, 23:176-184. 10.1038/13802 10508513
12. Harkin DP Bean JM Miklos D Song YH Truong VB Englert C Christians FC Ellisen LW Maheswaran S Oliner JD Haber DA Induction of GADD45 and JNK/ SAPK-dependent apoptosis following inducible expression of BRCA1 Cell 1999, 97:575-586. 10.1016/S0092-8674(00)80769-2 10367887
13. Blaszyk H Hartmann A Sommer SS Kovach JS A polymorphism but no mutations in the GADD45 gene in breast cancers Hum Genet 1996, 97:543-547. 10.1007/ BF02267084 8834260
14. Campomenosi P Hall PA Gadd45 mutations are uncommon in human tumour cell lines Cell Prolif 2000, 33:301-306. 10.1046/j.1365-2184.2000.00187.x 11063132
15. Yamasawa K Nio Y Dong M Yamaguchi K Itakura M Clinicopathological significance of abnormalities in Gadd45 expression and its relationship to p53 in human pancreatic cancer Clin Cancer Res 2002, 8:2563-2569. 12171884
16. Sakamoto A Oda Y Tsuneyoshi M Iwamoto Y Expression of the UV-induced molecule, Gadd45, in atypical fibroxanthoma Histopathology 2007, 50:939-941. 10.1111/j.1365-2559.2007.02685.x 17543084
17. Sakamoto A Oda Y Itakura E Oshiro Y Nikaido O Iwamoto Y Tsuneyoshi M Immunoexpression of ultraviolet photoproducts and p53 mutation analysis in atypical fibroxanthoma and superficial malignant fibrous histiocytoma Mod Pathol 2001, 14:581-588. 10.1038/modpathol.3880354 11406660
18. Gessner C Liebers U Kuhn H Stiehl P Witt C Schauer J Wolff G BAX and p16INK4A are independent positive prognostic markers for advanced tumour stage of nonsmall cell lung cancer Eur Respir J 2002, 19:134-140. 10.1183/09031936.02.00219402 11843312
19. Zhu XQ Shi YF Cheng XD Zhao CL Wu YZ Immunohistochemical markers in differential diagnosis of endometrial stromal sarcoma and cellular leiomyoma Gynecol Oncol 2004, 92:71-79. 10.1016/j.ygyno.2003.08.038 14751141
20. Aragane Y Kulms D Metze D Wilkes G Poppelmann B Luger TA Schwarz T Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/ APO-1) independently of its ligand CD95L J Cell Biol 1998, 140:171-182. 2132609 9425165 10.1083/jcb.140.1.171
21. Vogelstein B Lane D Levine AJ Surfing the p53 network Nature 2000, 408:307-310. 10.1038/35042675 11099028
22. Latonen L Taya Y Laiho M UV-radiation induces dose-dependent regulation of p53 response and modulates p53-HDM2 interaction in human fibroblasts Oncogene 2001, 20:6784-6793. 10.1038/sj.onc.1204883 11709713
23. Dilek FH Akpolat N Metin A Ugras S Atypical fibroxanthoma of the skin and the lower lip in xeroderma pigmentosum Br J Dermatol 2000, 143:618-620. 10.1111/j.1365-2133.2000.03721.x 10971340
24. Weedon D Strutton G Skin Pathology London: Elsevier Science; 2 2002.
25. Lee H Park G Jung JH Ahn WS Lee JM Kim BK Kang CS Diagnostic approach using the expression profiling of the P53 tumor suppressor gene and its related proteins in ovarian epithelial tumors Int J Gynecol Cancer 2005, 15:453-461. 10.1111/j.1525-1438.2005.15308.x 15882169
26. Marx D Binder C Meden H Lenthe T Ziemek T Hiddemann T Kuhn W Schauer A Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer Anticancer Res 1997, 17:2233-2240. 9216694
27. Westermann FN Langlois NE Simpson JG Apoptosis in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma Am J Dermatopathol 1997, 19:228-231. 10.1097/00000372-199706000-00005 9185907
28. Osaki M Osaki M Yamashita H Shomori K Yoshida H Ito H Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis Int J Mol Med 2002, 10:161-168. 12119552
29. Smith-Zagone MJ Prieto VG Hayes RA Timperman WW Jr Diwan AH HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: A case report J Cutan Pathol 2004, 31:284-286. 10.1111/ j.0303-6987.2004.00173.x 14984584
30. Hultgren TL DiMaio DJ Immunohistochemical staining of CD10 in atypical fibroxanthomas J Cutan Pathol 2007, 34:415-419. 10.1111/ j.1600-0560.2006.00635.x 17448198
31. Weedon D Williamson R Mirza B CD10, a useful marker for atypical fibroxanthomas Am J Dermatopathol 2005, 27:181. 10.1097/ 01.dad.0000150766.74493.19 15798451
32. Hartel PH Jackson J Ducatman BS Zhang P CD99 immunoreactivity in atypical fibroxanthoma and pleomorphic malignant fibrous histiocytoma: A useful diagnostic marker J Cutan Pathol 2006, 33:24-28. 10.1111/ j.1600-0560.2006.00492.x 16972949
33. Lazova R Moynes R May D Scott G LN-2 (CD74). A marker to distinguish atypical fibroxanthoma from malignant fibrous histiocytoma Cancer 1997, 79:2115-2124. 10.1002/ (SICI)1097-0142(19970601)79:11<2115::AID-CNCR8>3.0.CO;2-N 9179057
34. Worrell JT Ansari MQ Ansari SJ Cockerell CJ Atypical fibroxanthoma: DNA ploidy analysis of 14 cases with possible histogenetic implications J Cutan Pathol 1993, 20:211-215. 10.1111/j.1600-0560.1993.tb00645.x 8396160
35. Oshiro Y Fukuda T Tsuneyoshi M Atypical fibroxanthoma versus benign and malignant fibrous histiocytoma. A comparative study of their proliferative activity using MIB-1, DNA flow cytometry, and p53 immunostaining Cancer 1995, 75:1128-1134. 10.1002/ 1097-0142(19950301)75:5<1128::AID-CNCR2820750512>3.0.CO;2-H 7850711
36. Sakamoto A Oda Y Itakura E Oshiro Y Tamiya S Honda Y Ishihara A Iwamoto Y Tsuneyoshi M H-, K-, and N-ras gene mutation in atypical fibroxanthoma and malignant fibrous histiocytoma Hum Pathol 2001, 32:1225-1231. 10.1053/hupa.2001.28953 11727262
37. Tommasi S Swiderski PM Tu Y Kaplan BE Pfeifer GP Inhibition of transcription factor binding by ultraviolet-induced pyrimidine dimers Biochemistry 1996, 35:15693-15703. 10.1021/bi962117z 8961932